|
|
Volumn 49 Suppl 1, Issue , 2009, Pages
|
|
Fate of the beta-cell in the pathophysiology of type 2 diabetes.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIDIABETIC AGENT;
GASTRIC INHIBITORY POLYPEPTIDE;
GLUCAGON LIKE PEPTIDE 1;
INCRETIN;
INSULIN;
DISEASE COURSE;
DRUG EFFECT;
GLUCOSE BLOOD LEVEL;
HUMAN;
IMPAIRED GLUCOSE TOLERANCE;
INSULIN RESISTANCE;
METABOLISM;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PANCREAS ISLET BETA CELL;
PATHOPHYSIOLOGY;
REVIEW;
RISK FACTOR;
BLOOD GLUCOSE;
DIABETES MELLITUS, TYPE 2;
DISEASE PROGRESSION;
GASTRIC INHIBITORY POLYPEPTIDE;
GLUCAGON-LIKE PEPTIDE 1;
HUMANS;
HYPOGLYCEMIC AGENTS;
INCRETINS;
INSULIN;
INSULIN RESISTANCE;
INSULIN-SECRETING CELLS;
PREDIABETIC STATE;
RISK FACTORS;
|
|
EID: 70350495820
PISSN: None
EISSN: 15443450
Source Type: Journal
DOI: 10.1331/JAPhA.2009.09076 Document Type: Review |
|
Times cited : (43)
|
|
References (72)
|
